Across TCGA pan-cancer cohorts, USP9YP7 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated USP9YP7 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher USP9YP7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP9YP7 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

UCEC, ESCA, and PRAD are the cancer types where USP9YP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.046	0.927	<.001	108	view →
ESCA	OS	Tertile	All	0.205	0.911	<.001	54	view →
PRAD	OS	Tertile	All	0.265	0.884	<.001	12	view →
STAD	DFS	Tertile	II,III,IV	1.000	0.469	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: USP9YP7 tumor-vs-normal RNA expression · all USP9YP7 data types